Proprietary Drug Development
BOL is engaged in collaborations with universities, academic institutions, and hospitals to develop novel drugs and obtain regulatory approvals in the following therapeutic areas:
- Immunology and autoimmune indications – multiple sclerosis, glioblastoma, GVHD, scleroderma, immune thrombocytopenic purpura, endometriosis, Sjorgren’s syndrome
- CNS related – Parkinson’s disease, Epilepsy, ALS
- Pain Management – chronic pain, neuropathic diabetic pain, fibromyalgia
- Gastrointestinal diseases (IBD) – primary biliary cirrhosis, Crohn syndrome, ulcerative colitis
- Joint ailments – rheumatoid arthritis, osteoarthritis
- Dermatology – psoriasis, atopic dermatitis, vitiligo